Investor Relations

(Security Code :4506 TSE Prime)

Pick Up

Dec. 15, 2025	Sumitomo Pharma Selected as Highest Rating A-List Company by CDP for two consecutive years in the Category of Climate Change in the CDP 2025（PDF/250KB）	Sustainability
Dec. 09, 2025	Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition（PDF/221KB）	R&D
Dec. 05, 2025	Sumitomo Pharma Contributes to Relief Efforts for the Large-Scale Fire in Saganoseki, Oita City	Others
Dec. 01, 2025	Sumitomo Pharma Announces Personnel Change	Corporate
Nov. 07, 2025	Posted Conference on Q2 FY2025 Financial Results [Webcast]	Finances
Nov. 04, 2025	Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting（PDF/81KB）	R&D

Jan. 30, 2026	3nd Quarter of FY2025 financial results announcement (planned, 3:30 p.m.)